Co-Diagnostics, Inc. CODX
Co-Diagnostics, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 64.3% | 74.5% | 38.6% | 84.0% | 88.2% | 77.7% | 47.7% | 76.5% | 96.1% | — |
| Operating margin | -8058.8% | -1023.7% | -626.9% | -78.8% | 47.1% | 55.9% | -2741.6% | -15328.6% | -59567.6% | — |
| Net margin | -7533.6% | -961.4% | -518.7% | -41.6% | 37.5% | 57.0% | -2882.0% | -15714.3% | -90827.9% | — |
| FCF margin | -4793.2% | -763.8% | -344.2% | 15.0% | 41.3% | 36.7% | -2622.8% | -10326.4% | -43601.0% | — |
| Return on assets | -189.5% | -59.2% | -37.1% | -11.6% | 22.9% | 59.6% | -279.7% | -403.8% | -149.3% | -148.8% |
| Return on equity | -227.3% | -69.9% | -41.3% | -12.4% | 27.3% | 63.7% | -356.6% | 592.3% | -180.7% | 64.4% |
| Debt / equity | — | — | — | — | — | — | — | -1.80× | — | — |
| Current ratio | 3.87 | 4.41 | 10.81 | 23.94 | 9.14 | 16.69 | 4.83 | 0.45 | 7.09 | 0.31 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.